U.S. equities had a rough day on Tuesday as the 2016 presidential election tightened up, throwing uncertainty back into the air. The S&P 500 Index fell 0.7%, the Dow Jones Industrial Average dipped 0.6%, while the Nasdaq Composite dropped 0.7%.
Here’s how they did:
Square Inc (SQ)
SQ shares were up robustly on Wednesday morning on the strength of its third-quarter earnings report.
The financial services provider reported a loss of $32 million, or 9 cents per share. That was drastically better than the year-ago loss of 35 cents per share, and was a narrower loss than the 11-cents of red ink projected by analysts.
Revenues of $439 million were up 32% year-over-year and easily hurdled expectations for $430 million.
Gross payment volume — the combined total of all transactions processed using Square platforms — gained 39% YOY to $13.2 billion. The company’s cash advance and loan business was especially strong, surging 70% compared to the year-ago quarter. About 35,000 loans were processed, amounting to $208 million.
SQ shares responded with 5% gains in early Wednesday action, helping to cut into the company’s 15% year-to-date declines.
Electronic Arts Inc. (EA)
EA stock was up similarly on Wednesday after posting its fiscal second-quarter report last night.
The gaming company posted a loss of 13 cents per share, beating expectations for a 17-cent loss. However, revenue came in at about $898 million for the quarter, missing the average analysts’ outlook of $915 million. Digital sales amounted to a whopping 63% of net sales.
The release of FIFA 17 came later in the year compared to its predecessors — just four days before the end of the period — which had a negative effect on the company’s earnings. Still, the game sold better than expected and should help out in fiscal Q3 results.
Console games made up the largest segment of sales, amounting to $220 million.
EA shares were up 5% on Wednesday morning.
Gilead Sciences, Inc. (GILD)
GILD wasn’t so fortunate.
Biotech Gilead Sciences earned $2.75 per share on an adjusted basis last quarter, falling 6 cents below the consensus estimate. Though the company did register a slight beat on the revenue front, posting $7.5 billion in sales versus expectations for $7.46 billion.
U.S. product sales amounted to $5.1 billion, while European sales added up to $1.4 billion. This figure reached $452 million in Japan and $479 million in other locations.
For its fiscal year 2016, Gilead Sciences expects to rake in between $29.5 billion and $30.5 billion, which is in line with the $30.37 billion that analysts predict.
The news wasn’t enough to wake GILD shares from their 2016 slumber. The stock is off 26% year-to-date, and it’ll likely stay that way, as Gilead is mostly unchanged this morning.